The use of renin angiotensin aldosterone system inhibitors may be associated with decreased mortality after cancer surgery

Renin–angiotensin–aldosterone system (RAAS) inhibitors are antihypertensive agents with conflicting results on protective effects against some types of cancer. In light of these controversies, we aimed to study the effects of RAAS inhibitors in patients undergoing cancer surgery. From March 2010 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Ah Ran, Park, Jungchan, Lee, Jong-Hwan, Min, Jeong Jin, Gook, Joonhee, Jang, Jae Ni, Lee, Seung-Hwa, Kim, Kyunga, Ahn, Joonghyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046295/
https://www.ncbi.nlm.nih.gov/pubmed/35477724
http://dx.doi.org/10.1038/s41598-022-10759-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046295/
https://www.ncbi.nlm.nih.gov/pubmed/35477724
http://dx.doi.org/10.1038/s41598-022-10759-y

Ejemplares similares